Innovation Pipeline — Behavioral Health, GLP-1s, and Specialty Pharmacy

When CEO David Cordani and CEO-elect Brian Evanko talk about Cigna's growth, three innovation areas keep coming up: the Evernorth Behavioral Care Group expansion, GLP-1 weight-loss drug management through EncircleRx, and specialty pharmacy growth via Accredo. This module gives candidates the substance to discuss each, including specific provider counts, patient outcomes, and the competitive logic behind each bet — material that distinguishes a thoughtful candidate from one who just read the careers page.